Back
Speaker illustration

Doctor Tomoko Ichiki

Mayo Clinic, Division of Cardiovascular Diseases and Internal Medicine, Rochester (United States of America)

Presentations

Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Access
0
Thumbnail

Circulating corin in the general community: link to gender and metabolic dysfunction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Risk factors and prevention

Access
0
Thumbnail

Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Drug therapy of heart failure

Access
0
Thumbnail

This platform is supported by

logo Novo Nordisk